Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development.

The application of liquid chromatography/mass spectrometry (LC/MS) followed by principal components analysis (PCA) has been successfully applied to the screening of rat urine following the administration of three candidate pharmaceuticals. With this methodology it was possible to differentiate the control samples from the dosed samples and to identify the components of the mass spectrum responsible for the separation. These data clearly show that LC/MS is a viable alternative, or complementary, technique to proton NMR for metabonomics applications in drug discovery and development.

[1]  R. Plumb,et al.  Direct analysis of pharmaceutical compounds in human plasma with chromatographic resolution using an alkyl-bonded silica rod column. , 2001, Rapid communications in mass spectrometry : RCM.

[2]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  E Holmes,et al.  Chemometric models for toxicity classification based on NMR spectra of biofluids. , 2000, Chemical research in toxicology.

[4]  R. Plumb,et al.  Use of monolithic silica columns to increase analytical throughput for metabolite identification by liquid chromatography/tandem mass spectrometry , 2001 .

[5]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Marta Cascante,et al.  Metabolic profiling of cell growth and death in cancer: applications in drug discovery. , 2002, Drug discovery today.

[7]  I. J. Fraser,et al.  The rapid identification of drug metabolites using capillary liquid chromatography coupled to an ion trap mass spectrometer. , 1999, Rapid communications in mass spectrometry : RCM.

[8]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[9]  R. Plumb,et al.  Determination of 4-hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.

[10]  J P Shockcor,et al.  Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. , 1996, Analytical chemistry.

[11]  R. Plumb,et al.  Use of generic fast gradient liquid chromatography-tandem mass spectroscopy in quantitative bioanalysis. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[12]  G. Bowers,et al.  Automated SPE and tandem MS without HPLC columns for quantifying drugs at the picogram level , 1997 .

[13]  E Holmes,et al.  NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. , 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[14]  I. Wilson,et al.  An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse , 2000, FEBS letters.

[15]  R. Plumb,et al.  The potential of serially coupled alkyl-bonded silica monolithic columns for high resolution separations of pharmaceutical compounds in biological fluids , 2002 .

[16]  J. Nicholson,et al.  A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study , 2000 .